
How Trump's "big, beautiful bill" could affect Tampa Bay
Why it matters: Tampa Bay's working-class and older residents are expected to be the hardest hit.
"If you're someone who relies on social programs," he tells Axios, "you're going to be negatively affected."
State of play: The bill slashes funds for Medicare and Medicaid — the former provides health coverage for seniors as well as those with disabilities, while the latter helps those with low income.
Cuts to both programs will impact the region's healthcare industry and its outcomes, says Jeff Felardo, associate professor of economics at Eckerd College.
"Fewer people will be able to access health care, and the cuts could also force smaller clinics to shut down simply because they no longer have the revenue to stay open," Snipes adds.
Between the lines: The cuts place the onus on state and local governments to make up for the losses, or else risk a "severe void" in critical services.
This comes as state lawmakers push for more tax cuts, Snipes tells Axios, potentially widening the gap between the services Florida is now responsible for and the revenue available to fund them.
Zoom in: " Because of Tampa Bay's location, the defunding of the National Oceanic and Atmospheric Administration (NOAA) and FEMA will have a greater impact here than the rest of the nation," says Felardo.
Felardo tells Axios that the Tampa Bay National Weather Service Office in Ruskin is at risk due to NOAA staff reductions and consolidation.
The bottom line: "There are still people and businesses that are recovering from last year's hurricanes in Tampa Bay," Snipe says. "If it's that hard to recover now, just think about how much harder it will be to recover when we don't have reliable weather forecasts or FEMA."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth-oriented sectors like healthcare, as they reduce the cost of borrowing for research and innovation and increase the present value of future earnings. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Research Tools & Consumables company Sotera Health Company (NASDAQ:SHC) jumped 5%. Is now the time to buy Sotera Health Company? Access our full analysis report here, it's free. Immuno-Oncology company Incyte (NASDAQ:INCY) jumped 5%. Is now the time to buy Incyte? Access our full analysis report here, it's free. Immuno-Oncology company Exact Sciences (NASDAQ:EXAS) jumped 7.9%. Is now the time to buy Exact Sciences? Access our full analysis report here, it's free. Medical Devices & Supplies - Specialty company Bausch + Lomb (NYSE:BLCO) jumped 3.1%. Is now the time to buy Bausch + Lomb? Access our full analysis report here, it's free. Senior Health, Home Health & Hospice company Addus HomeCare (NASDAQ:ADUS) jumped 3.3%. Is now the time to buy Addus HomeCare? Access our full analysis report here, it's free. Zooming In On Exact Sciences (EXAS) Exact Sciences's shares are quite volatile and have had 18 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 26 days ago when the stock dropped 3% as several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively. Additionally, some pharmaceutical and biotech companies experienced sharp drops following unfavorable news; for instance, Sarepta Therapeutics plunged after a report indicated another patient death tied to its experimental gene therapy, and GSK's blood cancer drug dosage was voted against by the FDA advisory committee. Broader market sentiment, including concerns about rising costs and inadequate pricing for 2025 plans among health insurers, also contributed to the downward pressure on healthcare equities. Exact Sciences is down 20.8% since the beginning of the year, and at $45.10 per share, it is trading 37.3% below its 52-week high of $71.93 from October 2024. Investors who bought $1,000 worth of Exact Sciences's shares 5 years ago would now be looking at an investment worth $517.20. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Yahoo
an hour ago
- Yahoo
Illinois Dems flock to Springfield for Governor's Day at State Fair
SPRINGFIELD, Ill. (WGN) — Top Democrats worked on their messaging at the Illinois State Fair on Wednesday ahead of the midterm elections. The annual party chairs brunch and fair gathering, dubbed Governor's Day, provided a platform to vent, with U.S. House minority leader Hakeem Jeffries in attendance as the brunch keynote speaker. 'Crashing the economy is something bad. Destroying Medicaid, as you know it, is something bad,' Jeffries said. 'Taking a chainsaw to Social Security is something bad. Raising costs on hard-working American taxpayers is something bad.' Wednesday also served as an opportunity for Illinois Democrats to shine a spotlight on top candidates for U.S. Senate, like Lt. Gov. Juliana Stratton, Congressman Raja Krishnamoorthi, and Congresswoman Robin Kelly. And while the Illinois primary election is seven months away, that didn't stop state Democrats from taking shots over campaign funding. Stratton has pledged not to take corporate PAC money, while Krishnamoorthi and Kelly have received such donations. 'I'm blessed to have tens of thousands of individual donors who have supported me and the reason is simple: they believe in our mission,' Krishnamoorthi said. 'A lot of people who say they don't take corporate money—and I'm talking about some of my colleagues,' Kelly said. 'They don't take corporate money, but they take the money I raise, so it's laundered through me.' Stratton is backed by billionaire Gov. JB Pritzker, who insiders believe will boost the Lt. Governor's campaign coffers down the homestretch. 'I want to make sure that I'm centering the voices of Illinois families and not corporate special interests,' Stratton said. That's a distinction.' Thursday will be Republican Day. While they control the White House and Congress, the Republican Party is currently a super minority struggling to recruit candidates for key races. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Axios
an hour ago
- Axios
Dems fear "vicious" primary
House Democrats are looking on in agony as Congressional Progressive Caucus chair Greg Casar (D-Texas) and Rep. Lloyd Doggett (D-Texas) appear destined to duke it out for a single congressional district. "They are going to be vicious," one senior House Democrat told Axios, speaking on the condition of anonymity to offer candid thoughts on a sensitive internal battle. Why it matters: It would pit a 36-year-old rising progressive star against a well-liked, 78-year-old stalwart of the left at a time when age is already one of Democrats' biggest headaches. "Most of us are TRYING to stay out," a senior House progressive wrote in a text to Axios. Zoom in: House Minority Leader Hakeem Jeffries is unlikely to pick sides in this member vs. member race, sources told Axios. A Democratic leadership aide said there's a zero percent chance Jeffries weighs in. State of play: Casar and Doggett would share a single Austin-based district under the new congressional map that Republican state legislators are proposing. Doggett, who has been repeatedly targeted by Republicans in redistricting during his more than 30 years in Congress, currently represents much of Austin and its suburbs. Casar, a former Austin city councilman first elected to Congress in 2022, represents parts of southern and eastern Austin in a district that snakes down to San Antonio. Under the new map, the Austin portions of Casar's district would be merged with Doggett's. Both lawmakers are angling to run in the new 37th district, which would be heavily Democratic and centered in Austin. Doggett wrote Sunday that "over 2/3 of my current constituents will remain in the Trump configured CD37" and that his "seniority is an asset, not a liability." He urged Casar to "not abandon his reconfigured CD35, in which he is the only incumbent," noting it would be majority Hispanic and arguing that Casar could "use his organizing skills and populist message to win over the disaffected, particularly disaffected Hispanic voters." Casar's chief of staff Stephanie Trinh wrote yesterday that Doggett sent out his email "without discussing it with Greg or his team" and said it contained "incorrect information." The bottom line: Casar is ruling out a run in the new 35th district, a San Antonio-area seat that voted for Trump by 10 percentage points and contains just a tenth of his current constituency.